124 related articles for article (PubMed ID: 22989374)
21. Epigenetics of hepatocellular carcinoma.
Toh TB; Lim JJ; Chow EK
Clin Transl Med; 2019 May; 8(1):13. PubMed ID: 31056726
[TBL] [Abstract][Full Text] [Related]
22. Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology.
Gong B; Kao Y; Zhang C; Sun F; Zhao H
Evid Based Complement Alternat Med; 2018; 2018():4365739. PubMed ID: 30584453
[TBL] [Abstract][Full Text] [Related]
23. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma.
Hung JH; Li CH; Yeh CH; Huang PC; Fang CC; Chen YF; Lee KJ; Chou CH; Cheng HY; Huang HD; Chen M; Tsai TF; Lin AM; Yen CH; Tsou AP; Tyan YC; Chen YA
Sci Rep; 2018 Aug; 8(1):12284. PubMed ID: 30115977
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers.
Singh AK; Kumar R; Pandey AK
Curr Chem Genom Transl Med; 2018; 12():9-26. PubMed ID: 30069430
[TBL] [Abstract][Full Text] [Related]
26. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of miR-143 inducing apoptosis of liver carcinoma cells through regulation of the NF-κB pathway.
Zheng Y; Yang F; Fu L; Liu K
Oncol Lett; 2018 Jun; 15(6):9567-9571. PubMed ID: 29844837
[TBL] [Abstract][Full Text] [Related]
28. Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates.
Xiao XH; Lv LC; Duan J; Wu YM; He SJ; Hu ZZ; Xiong LX
Molecules; 2018 Mar; 23(4):. PubMed ID: 29596304
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis reveals ncRNA-mediated molecular regulatory network driving secondary hair follicle regression in cashmere goats.
Zhou G; Kang D; Ma S; Wang X; Gao Y; Yang Y; Wang X; Chen Y
BMC Genomics; 2018 Mar; 19(1):222. PubMed ID: 29587631
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
[TBL] [Abstract][Full Text] [Related]
31. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.
Xu JH; Chang WH; Fu HW; Yuan T; Chen P
Mol Med Rep; 2018 May; 17(5):6472-6482. PubMed ID: 29512731
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Mir-224, Mir-215 and Mir-143 as Serum Biomarkers for HCV Associated Hepatocellular Carcinoma.
Mamdouh S; Khorshed F; Aboushousha T; Hamdy H; Diab A; Seleem M; Saber M
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3167-3171. PubMed ID: 29172295
[TBL] [Abstract][Full Text] [Related]
34. miRNAs, Melanoma and Microenvironment: An Intricate Network.
Romano G; Kwong LN
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112174
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.
Yue PY; Ha WY; Lau CC; Cheung FM; Lee AW; Ng WT; Ngan RK; Yau CC; Kwong DL; Lung HL; Mak NK; Lung ML; Wong RN
Sci Rep; 2017 Sep; 7(1):12012. PubMed ID: 28931826
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
Li Y; Wang Z; Li Y; Jing R
Oncol Lett; 2017 May; 13(5):3896-3904. PubMed ID: 28521487
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.
Wang J; Song W; Shen W; Yang X; Sun W; Qu S; Shang R; Ma B; Pu M; Tao K; Dou K; Li H
Oncol Res; 2017 Jan; 25(1):1-10. PubMed ID: 28081727
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.
Bradshaw G; Sutherland HG; Haupt LM; Griffiths LR
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27999330
[TBL] [Abstract][Full Text] [Related]
39. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.
Inokawa Y; Inaoka K; Sonohara F; Hayashi M; Kanda M; Nomoto S
Oncol Lett; 2016 Nov; 12(5):3662-3668. PubMed ID: 27900050
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
Thillai K; Lam H; Sarker D; Wells CM
Oncotarget; 2017 Feb; 8(8):14173-14191. PubMed ID: 27845911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
